€ 0
Overview
| Donor: | Novo Nordisk Haemophilia Foundation (NNHF) |
| Application procedure: | Full Proposal |
| Donor base: | Switzerland |
| Reference number: | - |
| Eligible applicants: | Non-Profit Organisation |
| Deadline: | 02.09.2024 |
Financial details
| Grant size: | Medium - up to $1,000,000 |
| Minimum grant size: | - |
| Total available budget: | 3.000.000$ |
| Funding type: | Grants |
| Maximum grant size: | - |
| Funding ratio: | up to 100% |
Sectors
- Capacity Building
- Health
Project Locations
Africa
Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Democratic Republic of the Congo, Djibouti, Egypt, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea Bissau, Ivory Coast, Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Morocco, Mozambique, Namibia, Niger, Nigeria, Republic of the Congo, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Western Sahara, Zambia, Zimbabwe
America
Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominica, Dominican Republic, Ecuador, El Salvador, French Guiana, Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, Uruguay, Venezuela
Asia
Afghanistan, Azerbaijan, Bahrain, Bangladesh, Bhutan, Brunei, Cambodia, China, East Timor, India, Indonesia, Iran, Iraq, Israel, Japan, Jordan, Kazakhstan, Korea, Kuwait, Kyrgyzstan, Laos, Lebanon, Malaysia, Maldives, Mongolia, Myanmar, Nepal, North Korea, Oman, Pakistan, Palestine, Philippines, Qatar, Russian Federation, Saudi Arabia, Singapore, South Korea, Sri Lanka, Syria, Taiwan, Tajikistan, Thailand, Turkey, Turkmenistan, United Arab Emirates, Uzbekistan, Vietnam, West Bank and Gaza, Yemen
Europe
Albania, Armenia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Georgia, Hungary, Kosovo, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Poland, Romania, Serbia, Slovakia, Slovenia, Ukraine
Description
1) Objective
Founded in 2005 and situated in Zurich, Switzerland, Novo Nordisk Haemophilia Foundation (NNHF) is a non-profit organisation dedicated to define and fund sustainable programs which improve access to quality care benefitting people with haemophilia and allied bleeding disorders in the developing world. They focus on:
- (1) capacity building – comprehensive training of healthcare professionals through lectures, workshops and/or manuals, creation and implementation of national treatment guidelines, educational material and other relevant tools;
- (2) awareness creation – educational initiatives for patients and their families, to support their ability to cope; media and awareness campaigns among community leaders, authorities and general society to improve public support and reach out to remote areas;
- and (3) diagnosis and registries – improvement of laboratory facilities and skills of staff in performing diagnosis programmes, focus on establishment of quality assurance processes; establishment or updating of registries.
2) Eligibility
The project applicant being the person responsible for the project should be a local medical expert with proven experience in haemophilia or allied bleeding disorders or a leading representative of a local patient association. If the project applicant is not identical with the legal representative(s) of the institution/organisation, the legalĀ representative(s) need/s to endorse the project with his/her signature of the application.
3) Location
The initiatives NNHF supports take place in developing or transition countries where some infrastructure is already present. These are preferably in the low, lower-middle and upper-middle income categories, as defined by the OECD Development Assistance Committee (OECD DAC) list.
4) Budget
They have a yearly budget of $3,000,000. They approve app. 20 projects per year. Average grant size is $150,000.
5) Application
Applications are done via their online application portal. The next application deadline is 2 September 2024.